カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

患者エンゲージメントソリューションの世界市場予測：コンポーネント別（ハードウェア、ソフトウェア、サービス）、配信モード別（オンプレミス、クラウド）、エンドユーザー別（プロバイダー、支払人）、用途別（家庭健康管理、財政状態）、治療領域別

◆英語タイトル：Patient Engagement Solutions Market by Component (Hardware, Software, Services), Delivery Mode (On Premise, Cloud), End User (Provider, Payer), Applications (Home Health, Financial Health), Therapeutic Area - Analysis and Global Forecast to 2025
◆商品コード：HIT 2767
◆発行会社（リサーチ会社）：MarketsandMarkets
◆発行日：2020年8月28日
◆ページ数：170
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥534,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥880,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
MarketsandMarkets社は患者エンゲージメントソリューションの世界市場が2020年119億ドルから2025年193億ドルまで、年平均10.1％成長すると予測しております。本調査レポートでは、患者エンゲージメントソリューションの世界市場について詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、コンポーネント別（ハードウェア、ソフトウェア、サービス）分析、配信モード別（オンプレミスソリューション、クラウドベースソリューション）分析、エンドユーザー別（プロバイダー、支払人、患者、その他）分析、用途別（健康管理、家庭健康管理、社会的・行動的管理、財政健全管理）分析、治療領域別（慢性疾患、女性健康、フィットネス）分析、地域別分析、競争状況、企業評価・情報などを含めております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・患者エンゲージメントソリューションの世界市場規模：コンポーネント別（ハードウェア、ソフトウェア、サービス）
・患者エンゲージメントソリューションの世界市場規模：配信モード別（オンプレミスソリューション、クラウドベースソリューション）
・患者エンゲージメントソリューションの世界市場規模：エンドユーザー別（プロバイダー、支払人、患者、その他）
・患者エンゲージメントソリューションの世界市場規模：用途別（健康管理、家庭健康管理、社会的・行動的管理、財政健全管理）
・患者エンゲージメントソリューションの世界市場規模：治療領域別（慢性疾患、女性健康、フィットネス）
・患者エンゲージメントソリューションの世界市場規模：地域別
・競争状況
・企業評価・情報
【レポートの概要】

“The patient engagement solutions market is projected to grow at a CAGR of 10.1% due to the 5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care.”
The global patient engagement solutions market is projected to reach USD 19.3 billion by 2025 from USD 11.9 billion in 2020, at a CAGR of 10.1% during the forecast period. The growth of this market is driven by the implementation of government regulations and initiatives to promote patient-centric care, increasing demand for patient engagement solutions, and the increasing utilization of mobile health apps. However, a lack of interoperability of PES and a dearth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.

The COVID-19 outbreak has created immense pressure on the medical practices of all sizes and healthcare facilities across the globe have been overwhelmed by the large number of patients visiting them on a daily basis. The rising prevalence of coronavirus disease has driven the demand for accurate diagnosis and treatment devices in several countries across the globe. The COVID-19 pandemic has also increased the need for social distancing among physicians and patients, which has driven the demand for remote patient monitoring and telehealth solutions and the need for the accurate and timely exchange of patient health records. Various players in this market have introduced COVID-19- related features into their existing patient engagement solutions, which are being made available to users free of cost. These has led to the growth in adoption of the Patient Engagement Solutions Market.

“Services component is expected to increase during the forecast period.”
On the basis of component, the patient engagement solutions market is segmented into software, hardware, and services. The services segment is said to grow at the highest rate due to the fact that the service component is indispensable in the application of deployed solutions. Additionally, increasing investments in the development of innovative service models that provide value-based patient-centered care is also driving the market for services.

“The cloud based delivery ode of solutions is expected to grow at the highest CAGR in 2019.”
On the basis of delivery mode, the patient engagement solutions market is segmented into on-premise and cloud-based solutions. The cloud-based solutions segment is expected to register the highest CAGR during the forecast period. The flexibility, scalability, and affordability offered by cloud-based solutions are supporting their growth in the patient engagement solutions market. Cloud-based solutions help healthcare organizations share and integrate information from different locations or systems in real-time.

“Health management application of patient engagement solutions accounts for the largest share in 2019.”
The patient engagement solutions market is segmented into health management, home health management, social and behavioral management, and financial health management. In 2019, the health management applications segment accounted for the largest share of the global patient engagement solutions market. The large share of this segment can be attributed to the increasing awareness among patients about the complexity of their disease conditions and their willingness to actively participate in maintaining their own health.

“Providers account for the largest end user market in the patient engagement solutions market in 2019.”
On the basis of end users, the patient engagement solutions market is segmented into providers, payers, patients, and other end users (including government bodies, employer groups, and pharmaceutical companies). In 2019, the providers segment accounted for the largest share of the global patient engagement solutions market. Providers are increasingly adopting patient engagement solutions to curtail rising healthcare costs, offer value-based care, and improve financial outcomes. Patient engagement solutions also help providers to improve patient experience, meet the increasing demand for convenient access to health information, and better serve patients to self-manage their care.

“Chronic disease account for the largest therapeutic use market in the patient engagement solutions market in 2019.”
Based on the therapeutic area, the patient engagement solutions market is segmented into chronic diseases, women’s health, fitness, and other therapeutic areas. In 2019, the chronic diseases segment accounted for the largest share of the global patient engagement solutions market. The large share of this segment can be attributed to the high burden of chronic diseases and the need to effectively manage these conditions while reducing the overall healthcare costs.

“North America dominates the patient engagement solutions market during the forecast period.”
The global patient engagement solutions market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share of the global patient engagement solutions market. Favorable government initiatives and regulations, the need to reduce healthcare costs, the rising prevalence of chronic diseases, and the presence of key market players in the region are the key factors driving the growth of the patient engagement solutions market in North America.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1 (41%), Tier 2 (31%) and Tier 3 (28%)
• By Designation: C-level: 44% and Managers and other level: 56%
• By Region: North America: 46%, Europe: 26%, Asia: 23%, and the RoW: 5%

McKesson Corporation (US), Allscripts (US), IBM (US), AdvancedMD (US), Cerner Corporation (US), Epic Systems Corporation (US) are a few dominant players in the Patient Engagement Solutions Market.

Research Coverage:
The report segments the patient engagement solutions market and forecasts its size, by volume and value, based on region (Asia Pacific, Europe, North America, and RoW), airbags type (frontal, knee, and side & curtain), seatbelts type (2-point and 3-point), vehicle (PC, LCV, Buses, and Trucks), electric vehicle (BEV, HEV, FCEV, and PHEV), by component (Airbag Inflator, ACU and Airbag).
The report also provides a comprehensive review of market drivers, restraints, opportunities, and challenges in the patient engagement solutions market. The report also covers qualitative aspects in addition to the quantitative aspects of these markets.

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the patient engagement solutions market and provides them information on key market drivers, restraints, challenges, and opportunities.

【レポートの目次】

1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 26
1.2.1 PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS 26
1.3 MARKET SCOPE 27
1.3.1 MARKETS COVERED 27
1.3.2 YEARS CONSIDERED FOR THE STUDY 27
1.4 CURRENCY 28
1.5 LIMITATIONS 28
1.5.1 SCOPE-RELATED LIMITATIONS 28
1.5.2 METHODOLOGY-RELATED LIMITATIONS 28
1.6 STAKEHOLDERS 28
1.7 SUMMARY OF CHANGES 29

2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.2 RESEARCH METHODOLOGY STEPS 30
FIGURE 1 RESEARCH METHODOLOGY: PATIENT ENGAGEMENT SOLUTIONS MARKET 30
FIGURE 2 RESEARCH DESIGN 31
2.2.1 SECONDARY DATA 31
2.2.1.1 Secondary sources 31
2.2.2 PRIMARY RESEARCH 33
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 33
2.2.2.1 Primary sources 34
2.2.2.2 Key insights from primary sources 34
2.3 MARKET SIZE ESTIMATION METHODOLOGY 35
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 35
2.4 MARKET ESTIMATION 36
FIGURE 5 RESEARCH METHODOLOGY: MARKET ESTIMATION 36
2.5 MARKET DATA ESTIMATION AND TRIANGULATION 37
FIGURE 6 DATA TRIANGULATION METHODOLOGY 37
2.6 ASSUMPTIONS FOR THE STUDY 38

3 EXECUTIVE SUMMARY 39
FIGURE 7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2020 VS. 2025 (USD MILLION) 39
FIGURE 8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2020 VS. 2025 (USD MILLION) 40
FIGURE 9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 41
FIGURE 10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 41
FIGURE 11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2020 VS. 2025 (USD MILLION) 42
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET 43

4 PREMIUM INSIGHTS 44
4.1 PATIENT ENGAGEMENT SOLUTIONS MARKET OVERVIEW 44
FIGURE 13 GOVERNMENT INITIATIVES FOR PATIENT-CENTRIC CARE TO DRIVE MARKET GROWTH 44
4.2 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE
& COUNTRY (2019) 45
FIGURE 14 ON-PREMISE SOLUTIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019 45
4.3 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY COMPONENT, 2020 VS. 2025 45
FIGURE 15 SOFTWARE SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE
IN 2020 45
4.4 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY DELIVERY MODE,
2020 VS. 2025 46
FIGURE 16 ON-PREMISE SOLUTIONS WILL ACCOUNT FOR THE LARGEST MARKET SHARE IN 2025 46
4.5 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY APPLICATION, 2020 VS. 2025 46
FIGURE 17 HEALTH MANAGEMENT APPLICATIONS DOMINATE THE PATIENT ENGAGEMENT SOLUTIONS MARKET 46
4.6 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY END USER, 2020 VS. 2025 47
FIGURE 18 HEALTHCARE PROVIDERS ARE THE LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS 47
4.7 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY THERAPEUTIC AREA,
2020 VS. 2025 47
FIGURE 19 CHRONIC DISEASES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2025 47

5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
FIGURE 20 PATIENT ENGAGEMENT SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
5.2.1 DRIVERS 49
5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care 49
5.2.1.2 Increasing adoption of patient engagement solutions 49
5.2.1.3 Rising number of collaborations and partnerships between stakeholders 50
TABLE 1 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2018–2020 50
5.2.1.4 Increasing utilization of mobile health apps 50
5.2.2 RESTRAINTS 51
5.2.2.1 Requirement of investments in infrastructure for implementing patient engagement solutions 51
5.2.2.2 Protection of patient information 51
5.2.2.3 Lack of interoperability 52
5.2.2.4 Dearth of skilled IT professionals in the healthcare industry 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Emerging Asian countries 52
5.2.3.2 Wearable health technology 53
5.2.3.3 Cloud-based models 53
5.2.4 CHALLENGES 53
5.2.4.1 High cost of deployment 53
5.2.4.2 Lack of health literacy 54
5.3 IMPACT OF COVID-19 ON THE PATIENT ENGAGEMENT SOLUTIONS MARKET 54

6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT 55
6.1 INTRODUCTION 56
TABLE 2 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 56
6.2 HARDWARE 56
6.2.1 HARDWARE SOLUTIONS PROVIDE INTERACTIVE EXPERIENCE FOR PATIENTS AND THEIR FAMILIES 56
TABLE 3 HARDWARE SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION) 57
6.3 SOFTWARE 57
TABLE 4 SOFTWARE SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION) 57
TABLE 5 SOFTWARE SOLUTIONS MARKET, BY TYPE, 2018–2025 (USD MILLION) 58
6.3.1 STANDALONE SOFTWARE 58
6.3.1.1 Standalone software refers to the traditional software installed in client systems 58
TABLE 6 STANDALONE SOFTWARE SOLUTIONS MARKET, BY REGION,
2018–2025 (USD MILLION) 58
6.3.2 INTEGRATED SOFTWARE 59
6.3.2.1 Integrated software is the largest & fastest-growing segment of the PES software market 59
TABLE 7 INTEGRATED SOFTWARE SOLUTIONS MARKET, BY REGION,
2018–2025 (USD MILLION) 59
6.4 SERVICES 60
6.4.1 SERVICES SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 60
TABLE 8 SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 60
 
7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE 61
7.1 INTRODUCTION 62
TABLE 9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2018–2025 (USD MILLION) 62
7.2 ON-PREMISE SOLUTIONS 62
7.2.1 ON-PREMISE SOLUTIONS WILL CONTINUE TO DOMINATE THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN THE FORECAST PERIOD 62
TABLE 10 ON-PREMISE SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION) 63
7.3 CLOUD-BASED SOLUTIONS 63
7.3.1 CLOUD-BASED SOLUTIONS ARE PROJECTED TO REGISTER THE HIGHEST GROWTH DURING THE STUDY PERIOD 63
TABLE 11 CLOUD-BASED SOLUTIONS MARKET, BY REGION,
2018–2025 (USD MILLION) 64

8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER 65
8.1 INTRODUCTION 66
TABLE 12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 66
8.2 PROVIDERS 66
8.2.1 PROVIDERS ARE THE LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS 66
TABLE 13 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION, 2018–2025 (USD MILLION) 67
8.3 PAYERS 67
8.3.1 HEALTHCARE PAYER INDUSTRY IS WITNESSING CHANGES IN TERMS OF LEGISLATION AND COMPETITION 67
TABLE 14 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION, 2018–2025 (USD MILLION) 68
8.4 PATIENTS 68
8.4.1 INCREASING PARTICIPATION OF PATIENTS IN THEIR OWN CARE TO SUPPORT MARKET GROWTH 68
TABLE 15 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY REGION, 2018–2025 (USD MILLION) 68
8.5 OTHER END USERS 69
TABLE 16 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS,
BY REGION, 2018–2025 (USD MILLION) 69

9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION 70
9.1 INTRODUCTION 71
TABLE 17 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 71
9.2 HEALTH MANAGEMENT 71
9.2.1 HEALTH MANAGEMENT IS THE LARGEST & FASTEST-GROWING APPLICATION SEGMENT OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET 71
TABLE 18 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 72
9.3 HOME HEALTH MANAGEMENT 72
9.3.1 GROWING PREFERENCE FOR HOME HEALTHCARE TO SUPPORT MARKET GROWTH 72
TABLE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 72
9.4 SOCIAL & BEHAVIORAL MANAGEMENT 73
9.4.1 GROWING POPULARITY OF SOCIAL MEDIA WILL DRIVE MARKET GROWTH 73
TABLE 20 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 73
9.5 FINANCIAL HEALTH MANAGEMENT 74
9.5.1 FINANCIAL ENGAGEMENT SOLUTIONS HELP PROVIDERS MANAGE PATIENT PAYMENTS 74
TABLE 21 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 74

10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA 75
10.1 INTRODUCTION 76
TABLE 22 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA,
2018–2025 (USD MILLION) 76
10.2 CHRONIC DISEASES 76
TABLE 23 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES,
BY REGION, 2018–2025 (USD MILLION) 77
TABLE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES,
BY TYPE, 2018–2025 (USD MILLION) 77
10.2.1 CARDIOVASCULAR DISEASE 77
10.2.1.1 Cardiovascular disease is the leading cause of death globally 77
TABLE 25 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2018–2025 (USD MILLION) 78
10.2.2 DIABETES 78
10.2.2.1 High burden of diabetes to support market growth 78
TABLE 26 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY REGION, 2018–2025 (USD MILLION) 78
10.2.3 OBESITY 79
10.2.3.1 Rising prevalence of obesity to drive market growth 79
TABLE 27 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION, 2018–2025 (USD MILLION) 79
10.2.4 OTHER CHRONIC DISEASES 79
TABLE 28 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2018–2025 (USD MILLION) 80
10.3 WOMEN’S HEALTH 80
10.3.1 IMPROVED AWARENESS TO DRIVE MARKET GROWTH 80
TABLE 29 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH,
BY REGION, 2018–2025 (USD MILLION) 80
10.4 FITNESS 81
10.4.1 INCREASING PREFERENCE FOR A HEALTHY LIFESTYLE TO SUPPORT MARKET GROWTH 81
TABLE 30 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY REGION, 2018–2025 (USD MILLION) 81
10.5 OTHER THERAPEUTIC AREAS 82
TABLE 31 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2018–2025 (USD MILLION) 82

11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION 83
11.1 INTRODUCTION 84
TABLE 32 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION,
2018–2025 (USD MILLION) 84
11.2 NORTH AMERICA 85
FIGURE 21 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT 85
TABLE 33 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 86
TABLE 34 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY COMPONENT, 2018–2025 (USD MILLION) 86
TABLE 35 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY DELIVERY MODE, 2018–2025 (USD MILLION) 86
TABLE 36 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY END USER, 2018–2025 (USD MILLION) 87
TABLE 37 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 87
TABLE 38 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 87
11.2.1 US 88
11.2.1.1 The US is the largest market for patient engagement solutions 88
TABLE 39 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 89
TABLE 40 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2018–2025 (USD MILLION) 89
TABLE 41 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 89
TABLE 42 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 90
TABLE 43 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 90
11.2.2 CANADA 90
11.2.2.1 Growing need for cost containment to propel market growth 90
TABLE 44 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION) 91
TABLE 45 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION) 91
TABLE 46 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 92
TABLE 47 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 92
TABLE 48 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 92
11.3 EUROPE 93
TABLE 49 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 93
TABLE 50 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION) 93
TABLE 51 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION) 94
TABLE 52 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 94
TABLE 53 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 94
TABLE 54 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 95
11.3.1 GERMANY 95
11.3.1.1 Germany is the largest market for patient engagement solutions
in Europe 95
TABLE 55 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION) 96
TABLE 56 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION) 96
TABLE 57 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION) 96
TABLE 58 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 97
TABLE 59 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 97
11.3.2 FRANCE 97
11.3.2.1 Digital health insurance startups in France to support market growth 97
TABLE 60 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION) 98
TABLE 61 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION) 98
TABLE 62 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 99
TABLE 63 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 99
TABLE 64 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 99
11.3.3 UK 100
11.3.3.1 Favorable government initiatives to drive market growth 100
TABLE 65 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 100
TABLE 66 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE,
2018–2025 (USD MILLION) 101
TABLE 67 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 101
TABLE 68 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 101
TABLE 69 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 102
11.3.4 SPAIN 102
11.3.4.1 Data security concerns to hamper the market growth 102
TABLE 70 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 102
TABLE 71 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION) 103
TABLE 72 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 103
TABLE 73 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 103
TABLE 74 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 104
11.3.5 ITALY 104
11.3.5.1 Growing burden of chronic diseases is driving the demand for patient engagement solutions in the country 104
TABLE 75 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 104
TABLE 76 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION) 105
TABLE 77 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 105
TABLE 78 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 105
TABLE 79 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 106
11.3.6 REST OF EUROPE (ROE) 106
TABLE 80 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 106
TABLE 81 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION) 107
TABLE 82 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 107
TABLE 83 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 107
TABLE 84 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 108
11.4 ASIA PACIFIC 108
FIGURE 22 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT 109
TABLE 85 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 110
TABLE 86 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION) 110
TABLE 87 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY DELIVERY MODE, 2018–2025 (USD MILLION) 110
TABLE 88 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION) 111
TABLE 89 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 111
TABLE 90 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 111
11.4.1 JAPAN 112
11.4.1.1 Rising geriatric population in Japan to support market growth 112
TABLE 91 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION) 112
TABLE 92 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION) 113
TABLE 93 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 113
TABLE 94 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 113
TABLE 95 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 114
11.4.2 CHINA 114
11.4.2.1 China to register the highest growth in the patient engagement solutions market 114
TABLE 96 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION) 115
TABLE 97 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION) 115
TABLE 98 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 115
TABLE 99 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 116
TABLE 100 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 116
11.4.3 INDIA 116
11.4.3.1 High burden of chronic diseases to support market growth 116
TABLE 101 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 117
TABLE 102 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION) 117
TABLE 103 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 117
TABLE 104 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 118
TABLE 105 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 118
11.4.4 REST OF ASIA PACIFIC (ROAPAC) 118
TABLE 106 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION) 119
TABLE 107 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION) 119
TABLE 108 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 120
TABLE 109 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 120
TABLE 110 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 120
11.5 REST OF THE WORLD 121
TABLE 111 REST OF THE WORLD: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY REGION, 2018–2025 (USD MILLION) 121
TABLE 112 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 121
TABLE 113 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION) 121
TABLE 114 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER,
2018–2025 (USD MILLION) 122
TABLE 115 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 122
TABLE 116 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 122
11.5.1 LATIN AMERICA 123
11.5.1.1 Developments in healthcare infrastructure to support market growth 123
TABLE 117 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY COMPONENT, 2018–2025 (USD MILLION) 123
TABLE 118 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY DELIVERY MODE, 2018–2025 (USD MILLION) 123
TABLE 119 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION) 124
TABLE 120 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 124
TABLE 121 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 124
11.5.2 MIDDLE EAST & AFRICA 125
11.5.2.1 Rising government support to drive market growth 125
TABLE 122 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY COMPONENT, 2018–2025 (USD MILLION) 125
TABLE 123 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY DELIVERY MODE, 2018–2025 (USD MILLION) 126
TABLE 124 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY END USER, 2018–2025 (USD MILLION) 126
TABLE 125 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 126
TABLE 126 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,
BY THERAPEUTIC AREA, 2018–2025 (USD MILLION) 127

12 COMPETITIVE LANDSCAPE 128
12.1 OVERVIEW 128
12.2 MARKET EVALUATION FRAMEWORK 128
FIGURE 23 MARKET EVALUATION FRAMEWORK: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS WERE THE MOST WIDELY ADOPTED GROWTH STRATEGIES 128
 
12.3 MARKET RANKING 128
FIGURE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET RANKING, BY KEY PLAYER, 2019 128
12.4 KEY MARKET DEVELOPMENTS 129
12.4.1 PRODUCT LAUNCHES 129
TABLE 127 PRODUCT LAUNCHES, JANUARY 2017–JUNE 2020 129
12.4.2 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS 130
TABLE 128 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS,
JANUARY 2017–JUNE 2020 130
12.4.3 ACQUISITIONS 131
TABLE 129 ACQUISITIONS, JANUARY 2017–JUNE 2020 131
FIGURE 25 KEY DEVELOPMENTS BY PROMINENT PLAYERS IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET 132

13 COMPANY EVALUATION MATRIX & COMPANY PROFILES 133
13.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY 133
13.1.1 STAR 133
13.1.2 EMERGING LEADERS 133
13.1.3 EMERGING COMPANIES 133
13.1.4 PERVASIVE 133
FIGURE 26 COMPANY EVALUATION MATRIX: PATIENT ENGAGEMENT SOLUTIONS MARKET 134
13.2 COMPANY PROFILES 135
(Business overview, Products offered & Recent developments)*
13.2.1 MCKESSON CORPORATION 135
FIGURE 27 MCKESSON CORPORATION: COMPANY SNAPSHOT (2019) 135
13.2.2 ALLSCRIPTS HEALTHCARE, LLC 137
FIGURE 28 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2019) 137
13.2.3 IBM 139
FIGURE 29 IBM: COMPANY SNAPSHOT (2019) 139
13.2.4 ATHENAHEALTH 141
13.2.5 ORION HEALTH 142
13.2.6 CERNER CORPORATION 144
FIGURE 30 CERNER CORPORATION: COMPANY SNAPSHOT (2019) 144
13.2.7 GETWELLNETWORK, INC. 146
13.2.8 LINCOR SOLUTIONS 148
13.2.9 MEDHOST 149
13.2.10 HARRIS HEALTHCARE 150
13.2.11 GET REAL HEALTH 151
13.2.12 ONEVIEW HEALTHCARE 152
FIGURE 31 ONEVIEW HEALTHCARE: COMPANY SNAPSHOT (2019) 152
13.2.13 ADVANCEDMD 154
 
13.2.14 CUREMD HEALTHCARE 156
13.2.15 EPIC SYSTEMS CORPORATION 157
13.2.16 MEDITECH 158
FIGURE 32 MEDITECH: COMPANY SNAPSHOT (2019) 158
13.2.17 KAREO 159
13.2.18 ECLINICAL WORKS 160
13.2.19 SYMPHONYCARE 161
13.2.20 IQVIA 162
FIGURE 33 IQVIA: COMPANY SNAPSHOT (2019) 162
13.2.21 VIVIFY HEALTH 164
13.2.22 COGNIZANT 166
FIGURE 34 COGNIZANT: COMPANY SNAPSHOT (2019) 166
13.2.23 PATIENTSLIKEME 167
*Details on Business overview, Products offered & Recent developments might not be captured in case of unlisted companies.

14 APPENDIX 168
14.1 DISCUSSION GUIDE 168
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 172
14.3 AVAILABLE CUSTOMIZATIONS 174
14.4 RELATED REPORTS 174
14.5 AUTHOR DETAILS 175



【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[患者エンゲージメントソリューションの世界市場予測：コンポーネント別（ハードウェア、ソフトウェア、サービス）、配信モード別（オンプレミス、クラウド）、エンドユーザー別（プロバイダー、支払人）、用途別（家庭健康管理、財政状態）、治療領域別]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 遠隔医療の世界市場予測：コンポーネント別（ソフトウェア、サービス（RPM、RTM））、用途別（遠隔放射線診断、脳卒中遠隔医療、遠隔ICU）、ハードウェア別（グルコースメーター）、エンドユーザー別（プロバイダー、支払者、患者）、配信モード別（オンプレミス、クラウド）
    HIT 3542 / MarketsandMarkets / 2020年3月30日 / MarketsandMarkets社は遠隔医療の世界市場が、2020年255億ドルから2025年556憶ドルまで、年平均16.9％成長すると予測しています。本調査レポートでは、遠隔医療の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、コンポーネント別（ソフトウェア、サービス、ハードウェア）分析、用途別（遠隔放射線診断、脳卒中遠隔医療、遠隔ICU）分析、配信モード別（オンプレミス、クラウド）分析、エンドユーザー別（プロバイダー、支払者、患者）分析、地域別分析、競争状況、企業概要などを含め、次の構成でお届け致します。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場動向 ・遠隔医療の世界市場：コンポーネント別（ソフトウェア、サービス、ハードウェア） ・遠隔医療の世界市場：用途別（遠隔放射線診断、脳卒中遠隔医療、遠隔ICU） ・遠隔医療の世界市場：配信モード別（オンプレミス、クラウド） ・遠隔医療の世界市場：エンドユーザー別（プロバイダー、支払者、患者）...“The telehealth market is projected to grow at a CAGR of 16.9% during the forecast period (2020–2025).” The global telehealth market is projected to reach USD 55.6 billion by 2025 from USD 25.5 billion in 2020, at a CAGR of 16.9 % during the forecast period. The key factors driving the growth of this market include the need to expand healthcare access, the growing prevalence of chronic diseases and conditions, a shortage of physicians, advancements in telecommunications, and government support and raising awareness. However, regional variations in regulations, fraud, and the use of social media for care providers will restrict...
  2. 病院EMRシステムの世界市場予測：コンポーネント別（ソフトウェア、サービス、ハードウェア）、配信モード別（クラウド、オンプレミス）、種類別（専門EMR）、病院規模別（小規模、大規模病院）、地域別
    HIT 1238 / MarketsandMarkets / 2020年6月12日 / MarketsandMarkets社は病院EMRシステムの世界市場が2020年142億ドルから2025年207億ドルまで、年平均7.8％成長すると見込んでいます。本調査レポートでは、病院EMRシステムの世界市場を詳細に調査・分析し、イントロダクション、調査手法、プレミアムインサイト、市場概要、市場インサイト、コンポーネント別（サービス、ソフトウェア、ハードウェア） 分析、展開モード別（オンプレミス、クラウドベース）分析、種類別（一般EMRソリューション、専門EMRソリューション）分析、病院規模別（中・小規模病院、大病院）分析、地域別分析、競争状況、企業概要などを含めています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・市場インサイト ・病院EMRシステムの世界市場規模：コンポーネント別（サービス、ソフトウェア、ハードウェア） ・病院EMRシステムの世界市場規模：展開モード別（オンプレミス、クラウドベース）...“The global hospital EMR systems market is projected to reach USD 20.7 billion by 2025 from USD 14.2 billion in 2020, at a CAGR of 7.8% during the forecast period.” There is a growing inclination across the globe towards the adoption of EMR systems due to government support for the adoption of EMRs, an increase in the COVID-19 patient volume, and the rising need to curtail healthcare costs. “By component, the services segment accounted for the largest market share in 2019.” Based on components, the hospital EMR systems market is segmented into services, software, and hardware. The services segment accounted...
  3. 医療サプライチェーン管理の世界市場予測：コンポーネント別（ソフトウェア、在庫、注文、倉庫、購入、インプラント、輸送、戦略的ソーシング、委託、ハードウェア、バーコード、スキャナー、RFID）、配送別（オンプレミス、クラウド）、エンドユーザー別
    HIT 3312 / MarketsandMarkets / 2020年5月20日 / MarketsandMarkets社は医療サプライチェーン管理の世界市場が2020年22億ドルから2025年33億ドルまで、年平均7.9％成長すると予測しています。本調査レポートでは、医療サプライチェーン管理の世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、コンポネント別（ソフトウェア、ハードウェア）、配信モード別（オンプレミス配信、クラウドベース配信）、エンドユーザー別（メーカー、ディストリビューター、プロバイダー）、地域別、競争状況、企業概要などを含め、ご提供いたします。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・医療サプライチェーン管理の世界市場：コンポネント別（ソフトウェア、ハードウェア） ・医療サプライチェーン管理の世界市場：配信モード別（オンプレミス配信、クラウドベース配信） ・医療サプライチェーン管理の世界市場：エンドユーザー別（メーカー、ディストリビューター、プロバイダー） ・医療サプライチェーン管理の世界市場：地域別..."The healthcare supply chain management market is projected to grow at a CAGR of 7.9% during the forecast period (2020–2025)." The global healthcare supply chain management market size is projected to reach USD 3.3 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 7.9% during the forecast period. The key factors driving the growth of this market include the adoption of GS1 system of standard in the healthcare industry globally, the emergence of cloud-based solutions, reduction in operational costs by improving the efficacy and increase in overall profitability. However, the high cost of implementation of supply...
  4. リスクベース監視ソフトウェアの世界市場予測：エンドユーザー別（製薬＆バイオ製薬株式会社、医療機器株式会社、CRO）、配信モード別（Webホスト、オンプレミス、クラウドベース）、タイプ別（エンタープライズ、サイト）、コンポーネント別（ソフトウェア、サービス）
    HIT 7651 / MarketsandMarkets / 2020年5月29日 / MarketsandMarkets社はリスクベース監視ソフトウェアの世界市場が2020年2億7300万ドルから2025年5億1100万ドルまで、年平均13.3%％成長すると予測しています。本調査レポートでは、リスクベース監視ソフトウェアの世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別（エンタープライズRBMソフトウェア、ソフトウェアRBMサイト）、コンポネント別（ソフトウェア、サービス）、エンドユーザー別（製薬＆生物医薬品会社、契約調査組織（CROS）、医療機器会社、その他エンドユーザー）、地域別、競争状況、企業概要などを含め、ご提供いたします。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・リスクベース監視ソフトウェアの世界市場：種類別（エンタープライズRBMソフトウェア、ソフトウェアRBMサイト） ・リスクベース監視ソフトウェアの世界市場：コンポネント別（ソフトウェア、サービス） ・リスクベース監視ソフトウェアの世界市場：配信モード別（ウェブベース（オンデマンド）、ライセンス企業（オンプレミス）、クラウドベース（SAAS）） ・リスクベース監視ソフトウェアの世界市場：エンドユーザー別（製薬＆生物医薬品会社、契約調査組織（CROS）、医療機器会社、その他エンドユーザー）..."Risk-based monitoring (RBM) software market is projected to grow at a CAGR of 13.3%." The RBM software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3% during the forecast period. The RBM software market has witnessed various advancements in products and their approvals to meet the needs of the pharmaceutical research and development industry worldwide. Growth in the market can primarily be attributed to factors such as the cost and time efficiency of RBM solutions, rising number of clinical trials, and increasing government funding and grants to support...
  5. 人口健康管理の世界市場予測：構成要素別（ソフトウェア、サービス）、配信モード別（オンプレミス、クラウドベース）、エンドユーザー別（医療提供者、医療保険会社、政府機関）
    HIT 2429 / MarketsandMarkets / 2020年3月30日 / MarketsandMarkets社は人口健康管理の世界市場が、2020年229億ドルから2025年394憶ドルまで、年平均11.5％成長すると予測しています。本調査レポートでは、人口健康管理の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、構成要素別（ソフトウェア、サービス）分析、配信モード別（オンプレミス、クラウドベース）分析、エンドユーザー別（医療提供者、医療保険会社、その他）分析、地域別分析、競争状況、企業概要などを含め、次の構成でお届け致します。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場動向 ・人口健康管理の世界市場：構成要素別（ソフトウェア、サービス） ・人口健康管理の世界市場：配信モード別（オンプレミス、クラウドベース） ・人口健康管理の世界市場：エンドユーザー別（医療提供者、医療保険会社、その他） ・人口健康管理の世界市場：地域別...“The population health management market is projected to grow at a CAGR of 11.5% during the forecast period (2020–2025).” The global population health management market is projected to reach USD 39.4 billion by 2025 from USD 22.9 billion in 2020, at a CAGR of 11.5% during the forecast period. Government mandates and support for healthcare IT solutions, increasing use of big data analytics, and the need to curtail the escalating healthcare costs are the key factors driving the growth of the population health management market. In addition, emerging economies (such as Brazil, Russia, India, South Korea, and China), increasing focus...
  6. 現実世界証拠ソリューションの世界市場：治療領域別（心臓血管、腫瘍学、免疫学）、コンポーネント別（データセット、サービス）、エンドユーザー別（医療機器、支払者、医薬品、プロバイダー）、地域別
    BWC20MY001 / BlueWeave Consulting / 2019年10月 / 本調査レポートでは、現実世界証拠ソリューションの世界市場について調査・分析し、調査フレームワーク、調査手法、エグゼクティブサマリー、産業インサイト、市場概要、北米市場、ヨーロッパ市場、アジア太平洋市場、中南米市場、中東・アフリカ市場、企業情報などのデータを収録しています。 ・調査フレームワーク ・調査手法 ・エグゼクティブサマリー ・世界の現実世界証拠ソリューション産業インサイト ・世界の現実世界証拠ソリューション市場概要 ・北米の現実世界証拠ソリューション市場 ・ヨーロッパの現実世界証拠ソリューション市場 ・アジア太平洋の現実世界証拠ソリューション市場 ・中南米の現実世界証拠ソリューション市場...According to BlueWeave Consulting, the Global Real World Evidence Solutions Market is anticipated to grow at a steady rate during the forecast period. The global real-world evidence market is valued at 612.0 million in the year 2017 and projected to reach USD 1,348.1 million by the year 2023, at a CAGR of 14.3% during the forecast period. The global real-world evidence market is growing owing to several factors. The huge pharmaceutical organizations are discovered utilizing a clinico-genomic database with tumor sequencing data for disease revelation studies and focused on medication improvement. Organizations are along these lines ready to widen their...
  7. 医療サプライチェーン管理の世界市場2020-2026：コンポーネント別（ソフトウェア、ハードウェア）、配信モード別、エンドユーザー別、地域別
    BZW20JN001 / Bizwit Research & Consulting / 2020年5月28日 / ...Global Healthcare Supply Chain Management Market is valued approximately USD 1.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2020-2026. Today, the health care industry is beneath an immense pressure to provide high-quality care, as patients are increasingly demanding better medical facilities and services from patients around the world. Thus, healthcare organization and medical facilities are strictly following supply chain management practices. Healthcare supply chain management is concerned with the regulation of the flow of medical good & services from manufacturer to patients. Healthcare supply chain management...
  8. 患者エンゲージメントソリューションの世界市場予測（～2022年）：ハードウェア、ソフトウェア、サービス
    MAM-HIT-2767 / MarketsandMarkets / 2017年10月9日 / MarketsandMarketsが発行した当調査レポートでは、患者エンゲージメントソリューションの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、構成要素別分析、導入方式別分析、用途別分析、地域別分析、患者エンゲージメントソリューションの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Patient engagement solutions market is projected to register a CAGR of 16.2%”The global patient engagement solutions market is estimated to register a CAGR of 16.2% from 2017 to 2022, to reach USD 18.68 billion. The key factors driving the growth of the overall patient engagement solutions market include the rise in aging population, increasing burden of chronic diseases and focus of patients on self-managing their care has led to an increase in the adoption of patient engagement solutions globally. However, in spite of the numerous benefits certain barriers such as security of patient data and lack of interoperability are restraining...
  9. 新型コロナウイルス感染症の影響によるテレヘルス（遠隔診療）の世界市場2020-2026：コンポーネント別（ソフトウェア、サービス、ハードウェア）、用途別、エンドユーザー別、展開モード別、地域別
    BZW20JN001 / Bizwit Research & Consulting / 2020年5月25日 / 本調査レポートでは、新型コロナウイルス感染症の影響によるテレヘルス（遠隔診療）の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、コンポーネント別（ソフトウェア、サービス、ハードウェア）分析、用途別分析、エンドユーザー別分析、展開モード別分析、地域別分析、競争状況などを含め、次の構成でお届け致します。 ・エグゼクティブサマリー ・市場定義・範囲 ・市場動向 ・産業分析 ・新型コロナウイルス感染症の影響によるテレヘルス（遠隔診療）の世界市場：コンポーネント別（ソフトウェア、サービス、ハードウェア） ・新型コロナウイルス感染症の影響によるテレヘルス（遠隔診療）の世界市場：用途別 ・新型コロナウイルス感染症の影響によるテレヘルス（遠隔診療）の世界市場：エンドユーザー別 ・新型コロナウイルス感染症の影響によるテレヘルス（遠隔診療）の世界市場：展開モード別 ・新型コロナウイルス感染症の影響によるテレヘルス（遠隔診療）の世界市場：地域別...Global Telehealth Market is valued approximately at USD 21.73 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 17.5% over the forecast period 2020-2026. Telehealth delivers health related information and services through telecommunication technologies. It integrates various technologies which allows the delivery of healthcare facilities through virtual medical and health services. These services aid in the long-distance communication between patient and healthcare specialist and supports easy diagnosis, consultation, treatment and more. Factors such as growing population increases the demand for healthcare services alone with shortage of physicians drive the market growth. Further, rapid...
  10. 手術器具追跡システムの世界市場予測（〜2025）：技術別（RFID、バーコード）、コンポーネント別（ハードウェア（スキャナー）、ソフトウェア、サービス）、エンドユーザー別（病院（公共、プライベート））、地域別（北米、ヨーロッパ、アジア太平洋）、新型コロナウイルスの影響
    MD 4448 / MarketsandMarkets / 2020年8月20日 / Marketsandmarkets社は手術器具追跡システムの世界市場が2020年180百万ドルから2025年338百万ドルまで、年平均13.4％成長すると予測しています。本調査レポートでは、手術器具追跡システムの世界市場を調査・分析することで、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、技術別（バーコード、無線周波数識別（RFID））分析、コンポーネント別（ソフトウェア、ハードウェア、サービス）分析、エンドユーザー別（病院、その他）分析、産業別（金融、IT・通信、政府機関・公共行政、健康管理、教育）分析、地域別分析、競争状況、企業概要、近隣・関連市場など、今後の市場展望をまとめております。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場動向 ・手術器具追跡システムの世界市場規模：技術別（バーコード、無線周波数識別（RFID）） ・手術器具追跡システムの世界市場規模：コンポーネント別（ソフトウェア、ハードウェア、サービス） ・手術器具追跡システムの世界市場規模：エンドユーザー別（病院、その他） ・手術器具追跡システムの世界市場規模：産業別（金融、IT・通信、政府機関・公共行政、健康管理、教育）...“The surgical instrument tracking systems market is expected to grow at a CAGR of 13.4 % in the forecast period.” The surgical instrument tracking systems market is projected to reach USD 338 million by 2025 from USD 180 million in 2020, at a CAGR of 13.4% during the forecast period The tracking systems are gaining importance and is increasing in demand among healthcare providers due to the drive to reduce costs and increase efficiency. These systems ensure better inventory and asset management practices is a key aspect of this drive. End users such as hospitals are focused on minimizing the...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆